2017 Report details for project: Electronic Prescription Service (EPS) Release 2

Project name: Electronic Prescription Service (EPS) Release 2 - there are 5 reports for this project: 2013, 2014, 2015, 2016, 2017
Google search: Google search on project name (opens in new window) opens in new window
Organisation: DOH (D12) - see all reports for this organisation
Report year: 2017 (data is from Sept 2016)
Category: ICT - see all reports for this category
Description: The Electronic Prescription Service enables prescribers - such as GPs and practice nurses - to send prescriptions electronically to a dispenser (such as a pharmacy) of the patient's choice. This makes the prescribing and dispensing process more efficient and convenient for patients and staff.
DCA (RAG): Amber
DCA text: A Gate 5 Review is to be conducted in November 2016. The programme is due to close at the end of December 2016. Delivery of the remaining scope of the EPS Business Case (i.e. Phase 4) is expected to transfer to the Digitising Community Pharmacy and Medicines Programme under Paperless 2020 Domain E.
Start date: 2003-01-01
End date: 2016-12-31
Schedule text: Work is progressing in order to close the programme at the end of December 2016. Meetings have been scheduled with departments accross the organsiation to agree the handover of business as usual processes. The EPS Phase 4 pilot has been unable to begin as the GMS Regulations must be amended to reflect the change to the role of a prescriber when all prescriptions are sent via EPS and, following legal advice, this has been deemed to also apply to the pilot phase. NHS Digital are working with the Department of Health and NHS England to make the necessary changes to the Regulations and the Phase 4 pilot is therefore unlikely to start in 2016 or 2017. Replanning is underway and Phase 4 will transfer to the Digitising Community Pharmacy & Medicines programme within Domain E or Paperless 2020.
Baseline: £3.46m
Forecast: £5.58m
Variance: 61.00%
Variance text: Two change requests were submitted and approved to request additional funding to cover the cost of pharmacy training and the pre-requisites for Phase 4 and to rephase this funding to deliver the changes.
Whole Life Cost: £77.73m
WLCost text: Actuals are within the budgeted whole life costs.
Notes1:
Notes2:
Sourcefile: IPA_2017.csv

Home Selection Search All Reports All Projects (+dates) All Projects (+costs) All Organisations All Years All Categories


Acknowledgement: GMPP data has been re-used under the Open Government Licence.